The study, published in The Journal of Infectious Diseases, collected blood samples from 148 mothers and 122 newborns at birth, and again with 45 mothers and 48 babies six months later. Blood was taken from both vaccinated and unvaccinated mothers. Regarding the discrepancy in samples, researchers said some mothers dropped out while others had twins or triplets.
At birth, 78 percent of all babies sampled had detectable antibodies to SARS-CoV-2. All babies born to vaccinated moms had antibodies, as did about 3 out of 4 whose mothers were unvaccinated.
Investigators concluded that vaccinating after COVID-19 illness may be an effective strategy to boost antibodies in the babies.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.